Conditions: Diabetes Mellitus, Type 2
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 91
Healthy volunteers: yes

Brief summary:
An open-label, phase II study to assess the acute and chronic effects of empagliflozin (BI 10773)on fasting and postprandial glucose homeostasis in patients with IGT and type 2 diabetes mellitus and assess the acute effects of empagliflozin in healthy subjects.

Detailed description:

Arms:
arm 1: BI 10773 high dose once daily

Interventions: intervention 1: BI 10773
Intervention descriptions: intervention 1: BI 10773 tablets once daily high dose

Protocol document: